CAREERS |E-NEWS SIGN UP | CONTACT US | HOME     


< Back to News

BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
Thursday, December 14, 2017

PEI's BioVectra Inc. announced today a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to manufacture Ferric Citrate, the active pharmaceutical ingredient (API) in Auryxia® tablets - a medicine approved for the treatment of two common complications of chronic kidney disease.

View PDF